SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

OliX Corrects OLX10212 Trial Approval Disclosure

OliX corrected its OLX10212 Phase 2a trial approval disclosure, removing a New Zealand reference from the title.

Related stories